These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1902623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 6. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F, Ferro D, Valesini G, Quintarelli C, Saliola M, Grandilli MA, Balsano F.
    BMJ; 1990 Apr 28; 300(6732):1099-102. PubMed ID: 2111722
    [Abstract] [Full Text] [Related]

  • 7. Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns.
    Corrigan JJ, Jeter MA.
    Pediatrics; 1992 Jan 28; 89(1):43-6. PubMed ID: 1728019
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects].
    Kobayashi Y, Fukuo Y, Shibuya T, Terashi A.
    Nihon Ronen Igakkai Zasshi; 1990 Sep 28; 27(5):578-83. PubMed ID: 2124638
    [Abstract] [Full Text] [Related]

  • 12. Fluctuation of tPA and PAI-1 antigen levels in plasma: difference of their fluctuation patterns between male and female.
    Urano T, Sumiyoshi K, Nakamura M, Mori T, Takada Y, Takada A.
    Thromb Res; 1990 Oct 15; 60(2):133-9. PubMed ID: 2126399
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G.
    Stroke; 2000 Jan 15; 31(1):26-32. PubMed ID: 10625711
    [Abstract] [Full Text] [Related]

  • 15. Fluctuations of euglobulin lysis time, tissue plasminogen activator, and free and total plasminogen activator inhibitor levels in plasma in daytime.
    Takada A, Takada Y, Urano T, Sakakibara K, Rydzewski A.
    Thromb Res; 1990 Jan 01; 57(1):13-20. PubMed ID: 2105539
    [Abstract] [Full Text] [Related]

  • 16. The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus.
    Keeling DM, Campbell SJ, Mackie IJ, Machin SJ, Isenberg DA.
    Br J Haematol; 1991 Mar 01; 77(3):354-9. PubMed ID: 1707291
    [Abstract] [Full Text] [Related]

  • 17. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF.
    J Lab Clin Med; 1993 Nov 01; 122(5):606-15. PubMed ID: 8228580
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 01; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.
    Jurado M, Páramo JA, Gutierrez-Pimentel M, Rocha E.
    Thromb Haemost; 1992 Nov 10; 68(5):516-20. PubMed ID: 1455397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.